Patterns of progression in patients treated with nivolumab plus ipilimumab (NIVO plus IPI) versus sunitinib (SUN) for first-line treatment of advanced renal cell carcinoma (aRCC) in CheckMate 214.

被引：7

作者：

Tannir, Nizar M. ^{[1
]}

Motzer, Robert J. ^{[2
]}

Albiges, Laurence ^{[3
]}

Plimack, Elizabeth R. ^{[4
]}

George, Saby ^{[5
]}

Powles, Thomas ^{[6
]}

Donskov, Frede ^{[7
]}

Rini, Brian, I ^{[8
]}

Grunwald, Viktor ^{[9
]}

Hammers, Hans J. ^{[10
]}

Choueiri, Toni K. ^{[11
,12
]}

Gurney, Howard ^{[13
,14
]}

Tykodi, Scott S. ^{[15
]}

Porta, Camillo ^{[16
]}

Burotto, Mauricio ^{[17
]}

Tomita, Yoshihiko ^{[18
]}

Lee, Chung-Wei ^{[19
]}

Tang, Chad ^{[1
]}

McDermott, David F. ^{[20
]}

McKay, Rana R. ^{[21
]}

机构：

[1] UT MD Anderson Canc Ctr, Houston, TX USA

[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[3] Inst Gustave Roussy, Dept Canc Med, Villejuif, France

[4] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[5] Roswell Park Canc Inst, Buffalo, NY 14263 USA

[6] Queen Mary Univ London, Barts Canc Inst, London, England

[7] Aarhus Univ Hosp, Aarhus, Denmark

[8] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[9] Univ Hosp Essen, Essen, Germany

[10] UT Southwestern Kidney Canc Program, Dallas, TX USA

[11] Dana Farber Canc Inst, Boston, MA 02115 USA

[12] Harvard Med Sch, Boston, MA 02115 USA

[13] Westmead Hosp, Sydney, NSW, Australia

[14] Macquarie Univ, Sydney, NSW, Australia

[15] Univ Washington, Seattle, WA 98195 USA

[16] Univ Bari A Moro, Bari, Italy

[17] Bradford Hill Clin Res Ctr, Santiago, Chile

[18] Niigata Univ, Grad Sch Med & Dent Sci, Niigata, Japan

[19] Bristol Myers Squibb, Princeton, NJ USA

[20] Dana Farber Harvard Canc Ctr, Beth Israel Deaconess Med Ctr, Boston, MA USA

[21] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期

关键词：

D O I：

10.1200/JCO.2021.39.6_suppl.313

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

313

引用

页数：4